Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) and JV Partner Obtain Key Financing, Move Forward with Storm Copper Project Development

Aston Bay Holdings (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company, and its joint venture partner, American West Metals Limited, are making significant plans to move forward on development of the Storm Copper Project, located in Nunavut, Canada. The plans follow the announcement that American West secured nondilutive financing from a leading royalty […]

New European EM Contracts Give SuperCom Ltd. (NASDAQ: SPCB) Platform Broader Horizon in Growing Drive for Public Safety

Security solutions innovator SuperCom (NASDAQ: SPCB) is a growing provider of electronic monitoring technologies for a variety of primarily governmental client needs. Applications include the supervision of individuals in criminal cases who have qualified for home-based detention as an alternative to incarceration, as well as rehabilitation and domestic violence prevention programs. Most recently, the company […]

Astiva Health Inc. Leading the Way as Record Number of People Choose Medicare Advantage Plans

According to a recent KFF report, a record number of people enrolled in private Medicare Advantage plans last year (https://ibn.fm/YEpRJ). That trend bodes well for Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan that is committed to reshaping personalized and comprehensive healthcare. “For the first time in Medicare’s history, more than half of all […]

Nightfood Holdings Inc. (NGTF): Snacking Smarter, Sleeping Sounder, and Revolutionizing Service with Robots

Nighttime snacking is a $50+ billion market. The global robotic as-a-service market size was valued at $440 million in 2023, with a CAGR of 17.59% from 2024 to 2033, forecasted by Precedence Research. Nightfood Holdings (OTCQB: NGTF), a company focused on acquisitions in the hospitality, food service, and CPG sectors, isn’t just about satisfying late-night […]

D-Wave Quantum Inc. (NYSE: QBTS) Announces Partnership Extension and Launch of New Hybrid Quantum Solver

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, has announced an extension of its partnership with Aramco, a global leader in energy and chemicals, to address geophysical optimization challenges using quantum technology. Located in Delft, Netherlands, the Aramco Research Center (the “Center”) is dedicated to advancing computing technologies to tackle […]

DGE 5th Clinical Trials Agreements Conference To Discuss Transparency Among CTA Shareholders

DGE invites leaders, executives and professionals from the biotech, pharma, and medical device sectors, to attend the 5th Clinical Trials Agreements Conference being held August 21-22, 2024, in Philadelphia. The conference focuses on discussions such as accelerating negotiations, AI advancements, fair market value, and building a modern day clinical site budget. The event is hosted […]

Post-Conference Recap of the 4th PRC Performance Optimization Summit

The 4th PRC Performance Optimization Summit, held on June 5-6, 2024, in Philadelphia, gathered industry leaders to discuss optimizing promotional review committees (“PRC”). The summit featured sessions on compliance strategies, incorporating AI in PRC operations, and managing content updates for various digital platforms. Attendees benefited from expert presentations, interactive workshops, and networking opportunities aimed at […]

Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment

Clene (NASDAQ: CLNN), along with its subsidiary Clene Nanomedicine Inc., a biopharmaceutical company specializing in mitochondrial health to address neurological diseases like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment. The data was presented by Dr. Karen Ho, Clene’s Vice President of Translational Medicine, […]

 

From Our Blog

Earth Science Tech Inc. (ETST) Seeks to Implement a Unified Strategy to Unlock True Market Value and Support Shareholders

August 14, 2026

The recent annual financial results posted by Earth Science Tech (OTC: ETST) reflect significant success and growth, which the diversified holding company attributes to an overarching focus on optimizing internal operations. The company, for instance, logged consecutive year-over-year increases in revenue and gross profit in the two years to March 31, 2026 (https://ibn.fm/GQzTa), and has […]

Rotate your device 90° to view site.